Position in VYGR
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$13,234,284
+$5,842,898 QoQ
Shares Held
3,428,571
+82.3% QoQ
Ownership
5.67%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
19 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VYGR Over Time
Shares Held
Position Value (USD)
Derivatives in VYGR
reported options exposure · as of Dec 31, 2025CallValue
$176,064
CallShares
44,800
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026MILLENNIUM MANAGEMENT LLC holds $4,468,729,571 across 342 Biotechnology names. VYGR ranks #79 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JAZZ |
Jazz Pharmaceuticals plc
|
1,262,511 | $238,677,704 | |
| 2 | INSM |
INSMED Inc
|
1,157,786 | $189,321,166 | |
| 3 | BMRN |
Biomarin Pharmaceutical Inc
|
3,010,308 | $170,052,298 | |
| 4 | TERN |
Terns Pharmaceuticals, Inc.
|
3,011,558 | $158,769,337 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
447,887 | $148,192,371 | |
| 6 | FOLD |
AMICUS THERAPEUTICS, INC.
|
7,908,459 | $114,356,317 | |
| 7 | ARDX |
Ardelyx, Inc.
|
17,842,370 | $106,875,796 | |
| 8 | BLTE |
Belite Bio, Inc
|
570,088 | $90,894,830 |
All Filings in VYGR
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $13,234,284 | 3,428,571 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $176,064 | 44,800 | Call | Sole | 2026-02-17 | |
| 2025-12-31 | $7,391,386 | 1,880,760 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $10,706,923 | 2,292,703 | Shares | Sole | 2025-11-14 | |
| 2025-09-30 | $234,901 | 50,300 | Call | Sole | 2025-11-14 | |
| 2025-06-30 | $2,808,830 | 903,161 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $332,869 | 98,482 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $545,329 | 96,178 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $919,111 | 157,113 | Shares | Sole | 2024-11-14 | |
| 2024-03-31 | $937,749 | 100,725 | Shares | Sole | 2024-05-15 | |
| 2023-09-30 | $85,908 | 11,085 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $174,269 | 15,220 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $8,963,283 | 1,162,553 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $1,699,789 | 278,654 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $1,911,420 | 322,875 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $4,898,184 | 828,796 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $228,600 | 30,000 | Call | Sole | 2022-05-16 | |
| 2022-03-31 | $1,386,702 | 181,982 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $1,146,487 | 423,058 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $718,936 | 273,360 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $2,138,770 | 517,862 | Shares | Sole | 2021-08-16 | |
| 2020-03-31 | $2,034,026 | 222,298 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||